-
1دورية أكاديمية
المؤلفون: Ching-Yuan Wu, Yao-Hsu Yang, Yu-Shih Lin, Li-Hsin Shu, Yu-Ching Cheng, Hung-Te Liu, Yin-Yin Lin, I-Yun Lee, Wei-Tai Shih, Pei-Rung Yang, Ying-Ying Tsai, Geng-He Chang, Cheng-Ming Hsu, Reming-Albert Yeh, Yu-Huei Wu, Yu-Heng Wu, Rou-Chen Shen, Ming-Shao Tsai
المصدر: Heliyon, Vol 9, Iss 7, Pp e17701- (2023)
مصطلحات موضوعية: SARS-CoV-2, Spike protein, ACE2, Omicron variant, Mouth washing, TMPRSS2, Science (General), Q1-390, Social sciences (General), H1-99
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Ming-Shao Tsai, Wei-Tai Shih, Yao-Hsu Yang, Yu-Shih Lin, Geng-He Chang, Cheng-Ming Hsu, Reming-Albert Yeh, Li-Hsin Shu, Yu-Ching Cheng, Hung-Te Liu, Yu-Huei Wu, Yu-Heng Wu, Rou-Chen Shen, Ching-Yuan Wu
المصدر: Biomedicine & Pharmacotherapy, Vol 149, Iss , Pp 112802- (2022)
مصطلحات موضوعية: SARS-CoV-2, Spike protein, GB-1, Glycyrrhizic acid, COVID-19, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
3دورية أكاديميةGB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2
المؤلفون: Ming-Shao Tsai, Yao-Hsu Yang, Yu-Shih Lin, Geng-He Chang, Cheng-Ming Hsu, Reming-Albert Yeh, Li-Hsin Shu, Yu-Ching Cheng, Hung-Te Liu, Yu-Huei Wu, Yu-Heng Wu, Rou-Chen Shen, Ching-Yuan Wu
المصدر: Biomedicine & Pharmacotherapy, Vol 142, Iss , Pp 112011- (2021)
مصطلحات موضوعية: SARS-CoV-2, Spike protein, GB-2, Beta variant, Epsilon variant, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
4GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2
المؤلفون: Yu-Shih Lin, Chang Geng-He, Wu Ching-Yuan, Li-Hsin Shu, Cheng-Ming Hsu, Yao-Hsu Yang, Yu-Heng Wu, Ming-Shao Tsai, Yu-Huei Wu, Yu-Ching Cheng, Reming-Albert Yeh, Hung-Te Liu, Rou-Chen Shen
المصدر: Biomedicine & Pharmacotherapy, Vol 142, Iss, Pp 112011-(2021)
Biomedicine & Pharmacotherapyمصطلحات موضوعية: Conformational change, Lineage (genetic), medicine.drug_class, RM1-950, Spike protein, medicine.disease_cause, Monoclonal antibody, Antiviral Agents, Antioxidants, Catechin, Article, RBD, receptor binding domain, Theaflavin 3-gallate (Pubchem CID: 136825044), T3G, Theaflavin 3-gallate, Epsilon variant, Gallic Acid, Drug Discovery, medicine, Biflavonoids, Humans, Protein Interaction Domains and Motifs, GU, glycyrrhiza uralensis Fisch. ex DC, COVID-19, coronavirus disease 2019, Pharmacology, Infectivity, Medicine, East Asian Traditional, Mutation, biology, ACE2, angiotensin converting enzyme 2, SARS-CoV-2, The severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, HEK 293 cells, Wild type, COVID-19, General Medicine, Theaflavin (Pubchem CID: 135403798), Virology, Antibodies, Neutralizing, Beta variant, HEK293 Cells, Spike Glycoprotein, Coronavirus, biology.protein, Angiotensin-Converting Enzyme 2, (+)-Catechin (Pubchem CID: 9064), GB-2, Therapeutics. Pharmacology, Antibody, Protein Binding